Sansum Diabetes Research Institute

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1944-01-01

Employees: 11

Market Cap: -

Website: http://www.sansum.org

Clinical Trials

Active:1

Completed:30

Trial Phases

6 Phases

Early Phase 1:4

Phase 1:1

Phase 2:2

+3 more phases

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (27 trials with phase data)• Click on a phase to view related trials

Not Applicable

16 (59.3%)

Early Phase 1

4 (14.8%)

Phase 4

3 (11.1%)

Phase 2

2 (7.4%)

Phase 1

1 (3.7%)

Phase 3

1 (3.7%)

Community-Based Nutrition-Lifestyle Therapy for Pregnant Latina Women With Diabetes

Not Applicable

Completed

Conditions: Diabetes Mel Gestational - in Pregnancy
Diabetes Mellitus, Type 2

First Posted Date: 2024-01-23

Last Posted Date: 2025-04-03

Lead Sponsor: Sansum Diabetes Research Institute

Target Recruit Count: 15

Registration Number: NCT06218147

Locations: 🇺🇸
Sansum Diabetes Research Institute, Santa Barbara, California, United States

Acceptability & Impact of a Diabetes Management Smartphone App (mySugr) for Spanish-literate Adults With Type 2 Diabetes

Not Applicable

Completed

Conditions: Diabetes Mellitus, Type 2

First Posted Date: 2023-08-03

Last Posted Date: 2024-12-05

Lead Sponsor: Sansum Diabetes Research Institute

Target Recruit Count: 32

Registration Number: NCT05975242

Locations: 🇺🇸
Sansum Diabetes Research Institute, Santa Barbara, California, United States

Continuous Glucose Monitoring and Hass Avocado Trial ("CHAT")

Not Applicable

Terminated

Conditions: Dietary Habits
Diabetes Mellitus, Type 2

First Posted Date: 2022-03-24

Last Posted Date: 2023-11-30

Lead Sponsor: Sansum Diabetes Research Institute

Target Recruit Count: 50

Registration Number: NCT05293340

Locations: 🇺🇸
Sansum Diabetes Research Institute, Santa Barbara, California, United States

Integrating Abbott Point-of-Care Technologies and the Community Scientist Model to Support HbA1c Testing Per ADA

Active, not recruiting

Conditions: Diabetes Mellitus, Type 2
Cardiovascular Diseases

First Posted Date: 2021-08-11

Last Posted Date: 2025-04-02

Lead Sponsor: Sansum Diabetes Research Institute

Target Recruit Count: 750

Registration Number: NCT05000840

Locations: 🇺🇸
Sansum Diabetes Research Institute, Santa Barbara, California, United States

Comparison of Oral Semaglutide w/ Placebo- Treatment for Latino Adults w/T2 Diabetes Receiving Enhanced Lifestyle Care

Phase 4

Terminated

Conditions: Diabetes Mellitus, Type 2
Glucose Metabolism Disorders (Including Diabetes Mellitus)

Interventions: Drug: Semaglutide Pill
Dietary Supplement: Fresh organic vegetables

First Posted Date: 2021-06-24

Last Posted Date: 2023-05-25

Lead Sponsor: Sansum Diabetes Research Institute

Target Recruit Count: 12

Registration Number: NCT04938388

Locations: 🇺🇸
Sansum Diabetes Research Institute, Santa Barbara, California, United States

News